A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma
Clinical trial NCT04325828 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04325828
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-07
- Primary completion
- 2021-06-09
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.